upward move to the 11 area, probably beginning on Monday. Broke out of a pennant formation, which was in a Head & Shoulders longer-term formation. Probably some good news coming out next week, maybe about Orex's EU partner or perhaps the Light 50% Study!!
Don't worry, orex is getting ready to explode upward, next wk imo. The shorts are the Dumbest people I have ever seen in my life!!!!!
about the "so called early release of data by Orex" they are looking at the results of other more relevant test of contrave for causing heart attacks and they should be coming out with approval sometime this week, imo!
If contrave does a triple, obesity, heart, and diabetes because they are in partnership w/takeda trying to get it to be a diabetes drug then within 1 to 2 yrs 100!!!
I wish what you said about the price movement is true, but I think you are overly optimistic, though again hopefully it will come through. Personally I see Orex going to around 11, stopping consolidating between 9.50 to 11 and then taking off to 15 and maybe 20. I don't know about your time frame because I can see Orex easily at 20 in a years time but for the next 3 to 6 mos, I would think that we will go no higher than 15. But, if Takeda decides to buy Orex then I can see a buyout price of 20, shortly.
Amazing how the mkt is ignoring the success of Contrave and focusing on some stupid Forbes article and some jerk regulator who has some kind of ax to grind w/Orex. When mysimba is approved and it will be, I believe that the partnership arrangement will be almost as important, especiallly if Orex's EU partner is going to very aggresive in getting Mysimba in the EU Mkt.
is not as important as Orex's partner, imo. If Orex partners with Roche then Takeda if they really are interested in buying out Orex better act fast, because when Roche wants to buy a co, they don't fool around and they are not cheapskates. Yrs ago I had Syntex the co. that invented the birth control pill and they went from 35 down to around 11 before Roche bought them out at 23. I'm hoping that Orex partners w/Roche as I believe they will see the potential of Mysimba/Contrave and will consider buying them out.
Johnh-68, Thanks for the update and you are right, if the Mace study confirms then Orex is on its way to 11 and then some consolidation before it gets to 20. I believe that the Mace study will confirm the results of the 25% study!! If F said 3/3 then 2 weeks makes it 3/17 or no later, imo then 3/24. Orex is shareholder friendly and they are not going to stall releasing the data.
I rely on fundamentals and technical analysis to form an opinion. And the only reason I bought more of orex after the forbes article is because of this pattern, but for all that the future fundamentally of orex is bright!
Target should be around $11. Price the last couple of days tested neckline at 6.50 and Orex held. Next stop $11, Shorts be Afraid, Be Very Afraid!! Go Orex!!
The truth is if the 50% trial comes out showing orex benefits heart patients then the sky is the limit.
I thought that the decision will be announced on this Fri. And if the 50% confirms the 25% the sky is the limit for Orex.
You are 100% right, the Euros do not want to look like a bunch of sycophant toadies to the Americans and also Contrave will be approved as a weight loss drug in Europe not as a heart drug!
I saw Orex at 6.52 on the after-mkt and there is strong support at 6.50 and the close above 7 indicates to me that we have weathered the storm and the next info is on fri-Eu announcement which I believe will be positive, it should easily lift orex by at least one point, imo.
Orex will fly, next stop $10. The EU is an independent entity and they would look pretty foolish, imo if they let some dummies from the USA FDA influence their opinion. They would look like sycophant followers and they don't want that type of image. Also Orex had to disclose the Light study results to get a patent as a heart drug. This whole thing has been really over-blown!
the last 2 days is nothing more than a test of the neckline at 6.50. If Orex holds 6.50 and I believe it will, it should fulfill the Head & Shoulders target of around $10 a share. Go Orex!!